Kynam Capital Management, LP Caribou Biosciences, Inc. Call Options Transaction History
Kynam Capital Management, LP
- $837 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRBU
# of Institutions
135Shares Held
43.9MCall Options Held
25KPut Options Held
53.2K-
Black Rock Inc. New York, NY6.95MShares$16.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$9.53 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.27MShares$5.3 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.81MShares$4.22 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.55MShares$3.61 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $142M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...